Loading 活動

Cell Therapy Asia 2018


SELECTBIO is pleased to welcome you to Cell Therapy Asia 2018 which will be held in Kobe, Japan.

This conference brings together academic and industry participants focusing on many aspects of this rapidly expanding and evolving field including stem cells for cellular therapy, iPSCs and their deployment for research, pharmaceutical discovery and cellular therapy, immuno-oncology (IO) including CAR-T cell research and clinical application.

The conference addresses the whole ecosystem of Cell Therapy and Tissue Engineering with a focus on 3D-Culture, Organoids, Microfluidics technologies for constructing microphysiological systems.

In addition to presentations from academics, the program includes an emphasis on presentations from companies as well as posters to illustrate late-breaking research and an exhibit hall with companies seeking to engage with delegates from Europe, US, across Asia/Pacific and Japan.

With its strong biomedical research infrastructure, Kobe Japan is a perfect venue for Cell Therapy Asia 2018.


Call for Papers

If you would like to be considered for an oral presentation at this meeting, Submit an abstract for review now!

Oral Presentation Submission Deadline: 31 July 2018

Call for Posters

You can also present your research on a poster while attending the meeting. Submit an abstract for consideration now!

Poster Submission Deadline: 30 November 2018

Agenda Topics

  • 3D-Culture and Organoids
  • Clinical Trials and Commercialization of Cell Therapies
  • Cord Blood and Cord Blood-Derived Stem Cells for Cellular Therapy
  • Emerging Technologies and Emerging Companies Showcase
  • Immuno-Oncology (IO)
    • CAR-T Cells for Cancer Therapy
  • iPSC-derived Cells for Toxicity Testing, Screening and Cellular Therapy
  • Mesenchymal Stem Cells (MSCs): Their Potential for Cellular Therapy
  • Microfluidics Platforms for Building Microphysiological Systems Ex Vivo
  • Regulatory Landscape for Cellular Therapy
  • Stem Cell-derived Exosomes with Regenerative Potential
  • Stem Cells for Cellular Therapy
  • Tissue Engineering

Confirmed Speakers to date

Shizuka Akieda, Chief Executive Officer, Cyfuse Biomedical K.K.
Toshihiko Ezashi, Research Associate Professor, The University of Missouri
Kennedy Okeyo, Senior Lecturer, Institute for Frontier Life and Medical Sciences, Kyoto University
Hirofumi Suemori, Associate Professor, Laboratory of Embryonic Stem Cell Research, Institute for Frontier Life and Medical Sciences, Kyoto University
Masatoshi Suzuki, Associate Professor, Department of Comparative Biosciences and Stem Cell & Regenerative Medicine Center, University of Wisconsin-Madison


More Detail Coming Up Soon!

For More Information Please Contact GeneOnline:

[email protected] / +886-2-2514-0360